Hints and tips:
...At the mid-level, a cashmere style in a muted shade from Sheep Inc, John Smedley or — my favourite — Begg x Co will quickly become a staple of your wardrobe....
...“We are encouraged by these findings from Panoramic,” said Merck, which is known as MSD outside North America....
...Hans van Ees, a professor of corporate governance at the University of Groningen, said the real question for the board was whether AstraZeneca’s slip-ups were foreseeable....
...A road map on relevant regional co-operation was adopted in 2016....
...Keytruda, an immunotherapy made by Merck & Co, can now be prescribed to all cancer patients as long as they meet the genetic criteria....
...Ms Van Kleeck said the Air Force’s award underlined confidence in her company’s approach....
...“The families have control that is disproportionate to the amount of shares they hold,” says Herald van der Linde, head of Asia-Pacific equity strategy at HSBC....
...Top shareholdings: Resolute Forest Products; Dex Media; Cooper Tire & Rubber Company; IBM; Merck & Co; New York Times. Portfolio Value: $2.5bn....
...Renault and its partner Nissan announced in April a partnership with Daimler allowing the three companies to pool costs in small and electric cars, vans, and other technologies....
...As the Court’s argument continued in TSC Industries, Inc. v....
...Notable deals include German drug and chemical group Merck’s $6bn takeover of Millipore, the US laboratory supplies maker, and the decision by Grifols, Europe’s largest maker of blood-plasma products, to...
...Antoine van Agtmael coined the phrase “emerging markets” in 1981....
...“The cutback in capital spending will come back very quickly – it will be a classic ‘V’,” predicts Andrew Bartels, head of research at Forrester....
...French drugmaker Sanofi-Aventis declined sharply after it announced it would buy 50 per cent of its Merial animal health joint venture from US drugmaker Merck....
...“There is no Dutch generics industry any more,” says Gerard van Odijk, European president of Teva, the world’s largest generic drugs manufacturer....
...In other cases, the pain will be even more broadly felt, says Huw van Steenis, analyst at Morgan Stanley. “I think the bigger holders now of securitisations are insurance companies and pension funds.”...
...Bad news for leading drug makers Merck and Schering-Plough undercut positive sentiment Monday....
...Wyeth, Merck and other drugmakers face thousands of such suits potentially worth billions of dollars. The issue in the case is whether state law claims are pre-empted under federal law....
...But Merck’s superior gross margins and the strength of its near-term drug pipeline won this round....
...Manufacturer victories would be good news for an industry smarting from the Vioxx withdrawal, which cost Merck more than $6bn in legal and settlement costs....
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
...Greenberg represented C.V. Starr & Co. Playing to type Hollywood blockbusters are supposed to be escapist....
...Raymond Van Dyke, a patent expert at the law firm Nixon Peabody and chair of the biotechnology and public policy subcommittee of the American Intellectual Property Law Association, said the Merck ruling...
...Content and technology companies sectors that have found themselves at loggerheads over the effect of the internet are exploring ways to co-operate or combine....
...He was born in 1954, the year, as he points out, of the famous Brown v Board of Education case which paved the way for US desegregation....
International Edition